Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | HTR6 | P50406 | 4/20 | 0.52 |
| ▸ | HTR1D | P28221 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | BCHE | P06276 | 2/20 | 0.47 |
| ▸ | ACHE | P22303 | 2/20 | 0.47 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.46 |
| ▸ | NQO2 | P16083 | 1/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.46 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23608115 | 0.90 | ADRB2 (0.46) | ADRB2MAPTALDH1A1KDM4EMEN1 | |
| SCHEMBL23608109 | 0.90 | ADRB2 (0.46) | ADRB2MAPTALDH1A1KDM4EMEN1 | |
| SCHEMBL18927402 | 0.85 | KDM4E (0.53) | MAPTALDH1A1KDM4EMEN1HPGD | |
| SCHEMBL18927518 | 0.84 | PLA2G2A (0.54) | MAPTALDH1A1KDM4EMEN1HPGD | |
| SCHEMBL23777834 | 0.82 | POLB (0.62) | ADRB2ALDH1A1KDM4EMEN1HTT | |
| Fumaric Acid SCHEMBL23608110 | 0.81 | PLA2G2A (0.42) | ADRB2MAPTALDH1A1KDM4EMEN1 | |
| SCHEMBL6575542 | 0.81 | HTR6 (0.48) | ADRB2ALDH1A1HTR6PLA2G2AMTNR1B | |
| SCHEMBL18271569 | 0.81 | AKR1C3 (0.64) | MAPTALDH1A1KDM4EMEN1HPGD | |
| SCHEMBL10771285 | 0.80 | PLA2G4A (0.40) | ADRB2MAPTALDH1A1KDM4EHPGD | |
| Hydrochloric Acid SCHEMBL6579614 | 0.80 | HTR6 (0.48) | ADRB2ALDH1A1HTR6MTNR1BNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704826-A1 | COMPOSITIONS AND METHODS FOR TREATING POST-TRAUMATIC STRESS DISORDER | Yale University (US) | 2026-03-11 | — | — | EP | claimed |
| WO-2024226995-A1 | COMPOSITIONS AND METHODS FOR TREATING POST-TRAUMATIC STRESS DISORDER | YALE UNIVERSITY (US) | 2024-10-31 | — | — | WO | claimed |
| CN-118234491-A | Hallucinogen-fatty acid combinations | 明德赛特制药公司 | 2024-06-21 | — | — | CN | claimed |
| EP-4351568-A1 | HALLUCINOGEN-FATTY ACID COMBINATION | Mindset Pharma Inc. (CA) | 2024-04-17 | — | — | EP | claimed |
| EP-4346788-A2 | ENANTIOMERIC ENTACTOGEN COMPOSITIONS AND METHODS OF THEIR USE | Arcadia Medicine, Inc. (US) | 2024-04-10 | — | — | EP | claimed |
| WO-2023177294-A1 | TRANSMUCOSAL DELIVERY OF PSYCHOACTIVE COMPOUNDS | PLETHORA THERAPEUTICS B.V. (NL) | 2023-09-21 | — | — | WO | claimed |
| EP-4221682-A2 | METHODS FOR DELIVERY OF PSYCHEDELIC MEDICATIONS BY INHALATION AND SYSTEMS FOR PERFORMING THE METHODS | Cybin IRL Limited (IE) | 2023-08-09 | — | — | EP | claimed |
| WO-2022256720-A2 | ENANTIOMERIC ENTACTOGEN COMPOSITIONS AND METHODS OF THEIR USE | ARCADIA MEDICINE, INC. (US) | 2022-12-08 | — | — | WO | claimed |
| WO-2022069690-A2 | METHODS FOR DELIVERY OF PSYCHEDELIC MEDICATIONS BY INHALATION AND SYSTEMS FOR PERFORMING THE METHODS | CYBIN IRL LIMITED (IE) | 2022-04-07 | — | — | WO | claimed |
| CN-113956188-A | Synthesis method of N, N-dimethyl-5-methoxytryptamine | 河北维达康生物科技有限公司 | 2022-01-21 | — | — | CN | claimed |
| WO-2017189528-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | Ecolab USA, Inc. (US) | 2017-11-02 | — | — | WO | claimed |
| US-20170306504-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | CHAMPIONX LLC | 2017-10-26 | — | — | US | claimed |
| CN-105636438-A | Pharmaceutical composition comprising an AMPK activator and a serotonin active agent and uses thereof | CHEN JIANHONG | 2016-06-01 | — | — | CN | claimed |
| CN-103751943-A | Fire extinguishing composition containing nitrogenous organic compound | XI AN JIAN RUI SAFETY EMERGENCY EQUIPMENT LTD LIABILITY COMPANY | 2014-04-30 | — | — | CN | claimed |
| US-20120108510-A1 | METHODS OF IMPROVING BEHAVIORAL THERAPIES | EMORY UNIVERSITY (US) | 2012-05-03 | — | — | US | claimed |
| EP-2001877-A1 | METHOD FOR EXTRACTING TARGET ALKALOID USING AN IONIC LIQUID AS EXTRACTING SOLVENT | Bioniqs Limited (GB) | 2008-12-17 | — | — | EP | claimed |
| WO-2007110637-A1 | METHOD FOR EXTRACTING TARGET ALKALOID USING AN IONIC LIQUID AS EXTRACTING SOLVENT | BIONIQS LIMITED (GB) | 2007-10-04 | — | — | WO | claimed |
| US-12611417-B1 | Compositions and methods to inhibit acid-catalyzed dephosphorylation of phosphoryloxytryptamines | Convergent Health Sciences LLC: (US) | 2026-04-28 | — | — | US | disclosed |
| US-4882331-A | ANTIDEPRESSANTS | LES LABORATOIRES MERAM (FR) | 1989-11-21 | — | — | US | disclosed |
| EP-0288360-A1 | Derivatives of 1-[(1,1-diphenyl)-1-alkenyl] piperazine, process for their preparation and compositions containing them | Société anonyme: LES LABORATOIRES MERAM (FR) | 1988-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12611417-B1 | Compositions and methods to inhibit acid-catalyzed dephosphorylation of phosphoryloxytryptamines | PLCB1, PHKG1, PLCB3 | ADRB2 801/4885MAPT 2085/4885ALDH1A1 2191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.